These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 9374096

  • 1. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA, Hainsworth JD.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
    Hainsworth JD, Jones SE, Mennel RG, Blum JL, Greco FA.
    J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
    [Abstract] [Full Text] [Related]

  • 4. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S.
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [Abstract] [Full Text] [Related]

  • 5. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD, Jolivet J, Birch R, Hopkins LG, Greco FA.
    Cancer; 1997 Feb 15; 79(4):740-8. PubMed ID: 9024712
    [Abstract] [Full Text] [Related]

  • 6. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U, Harstrick A, Wilke H, Seeber S.
    Semin Oncol; 1996 Feb 15; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [Abstract] [Full Text] [Related]

  • 7. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
    Klaassen U, Wilke H, Müller C, Borquez D, Harstrick A, Seeber S.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
    Paul DM, Garrett AM, Meshad M, DeVore RD, Porter LL, Johnson DH.
    Semin Oncol; 1996 Feb 15; 23(1 Suppl 1):48-52. PubMed ID: 8629038
    [Abstract] [Full Text] [Related]

  • 9. Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
    Rahman Z, Champlin R, Rondon G, Frye D, Valero V, Mehra R, Hortobagyi G.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 17):S17-77-S17-80. PubMed ID: 9374100
    [Abstract] [Full Text] [Related]

  • 10. Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase II trial.
    Nicholson B, Paul D, Shyr Y, Garrett M, Hande KR, Johnson DH.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 11):S11-20-S11-23. PubMed ID: 9314294
    [Abstract] [Full Text] [Related]

  • 11. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
    Conte PF, Baldini E, Michelotti A, Salvadori B, Gennari A, Da Prato M, Tibaldi C, Giannessi PG, Gentile A.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 15):39-42. PubMed ID: 8996597
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
    Lück HJ, Thomssen C, du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [Abstract] [Full Text] [Related]

  • 16. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
    Catimel G, Spielmann M, Dieras V, Tubiana-Hulin M, Bonneterre J, Pouillart P, Kayitalire L, Guastalla JP, Graffand N, Garet F, Dumortier A, Pellae-Cosset B.
    Semin Oncol; 1997 Feb 15; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
    [Abstract] [Full Text] [Related]

  • 17. Treatment of metastatic breast cancer with paclitaxel and doxorubicin.
    Dombernowsky P, Gehl J, Boesgaard M, Jensen TP, Jensen BW, Ejlertsen B.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):13-7. PubMed ID: 8643964
    [Abstract] [Full Text] [Related]

  • 18. The sequential administration of combined doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Frassineti GL, Zoli W, Tienghi A, Ravaioli A, Milandri C, Gentile A, Salzano E, Amadori D.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 12):22-8. PubMed ID: 8941407
    [Abstract] [Full Text] [Related]

  • 19. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma.
    Holmes FA.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 8):9-15. PubMed ID: 7543702
    [Abstract] [Full Text] [Related]

  • 20. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW, Long GD, Stockerl-Goldstein KE, Johnston LJ, Chao NJ, Negrin RS, Blume KG.
    Clin Cancer Res; 1999 Nov 15; 5(11):3411-8. PubMed ID: 10589752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.